Literature DB >> 9726290

Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin.

J P Visapää1, K Jokelainen, T Nosova, M Salaspuro.   

Abstract

Heavy drinking is associated with many gastrointestinal symptoms and diseases, such as rapid intestinal transit time, diarrhea, colon polyps, and colorectal cancer. Acetaldehyde produced from ethanol by intestinal microbes has recently been suggested to be one of the pathogenetic factors related to alcohol-associated gastrointestinal morbidity. Furthermore, acetaldehyde is absorbed from the colon into portal blood and may thus contribute to the development of alcoholic liver injury. The present study was aimed to investigate the significance of gut aerobic flora in intracolonic acetaldehyde formation. For this study, 58 male Wistar rats (aged 9 to 11 weeks) were used. Half of the rats received ciprofloxacin for four consecutive days. Control rats (n = 29) received standard chow. On the fifth day of treatment, 1.5 g/kg body weight of ethanol was administered intraperitoneally to 19 rats receiving ciprofloxacin and 19 control rats. Ten ciprofloxacin-treated and 10 control rats received equal volumes of physiological saline intraperitoneally. Two hours after the injection of ethanol or saline, the samples of colonic contents and blood were obtained. Acetaldehyde and ethanol levels of the samples were determined by headspace gas chromatography. The intracolonic acetaldehyde level 2 hr after ethanol administration was 483+/-169 microM (maximum: 2.7 mM). High intracolonic acetaldehyde after ethanol injection was significantly reduced by ciprofloxacin treatment. After ciprofloxacin, intracolonic acetaldehyde levels before and after the injection of ethanol were 25+/-4.8 and 23+/-15 microM, respectively. Ciprofloxacin treatment resulted also in significantly higher blood (p < 0.005) and intracolonic (p < 0.0001) ethanol levels than in the control animals. Furthermore, ciprofloxacin treatment totally abolished the formation of endogenous ethanol in the large intestine. This study demonstrates that alcoholic fermentation and intracoIonic acetaldehyde production can be blocked by diminishing the amount of intracolonic aerobic bacteria with ciprofloxacin. Our findings indicate that the bacteriocolonic pathway for ethanol oxidation is mediated almost exclusively by gut aerobic microbes, and this knowledge may provide new insights into the studies on the pathogenesis of alcohol-related gastrointestinal symptoms and diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726290

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  12 in total

Review 1.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Gut region-dependent alterations of nitrergic myenteric neurons after chronic alcohol consumption.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

3.  Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.

Authors:  Heidi Koivisto; Johanna Hietala; Petra Anttila; Onni Niemelä
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

4.  Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis.

Authors:  Cheryl Marietta; Larry H Thompson; Jane E Lamerdin; P J Brooks
Journal:  Mutat Res       Date:  2009-04-05       Impact factor: 2.433

5.  Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents.

Authors:  Laurent Ferrier; Florian Bérard; Laurent Debrauwer; Chantal Chabo; Philippe Langella; Lionel Buéno; Jean Fioramonti
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 6.  Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers.

Authors:  S Singh; J Arcaroli; D C Thompson; W Messersmith; V Vasiliou
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.

Authors:  Michael J Duryee; Lynell W Klassen; Courtney S Schaffert; Dean J Tuma; Carlos D Hunter; Robert P Garvin; Daniel R Anderson; Geoffrey M Thiele
Journal:  Free Radic Biol Med       Date:  2010-08-06       Impact factor: 7.376

8.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

Review 9.  Alcoholic pancreatitis: A tale of spirits and bacteria.

Authors:  Alain Vonlaufen; Laurent Spahr; Minoti V Apte; Jean-Louis Frossard
Journal:  World J Gastrointest Pathophysiol       Date:  2014-05-15

Review 10.  Alterations of the gut microbiome and metabolome in alcoholic liver disease.

Authors:  Wei Zhong; Zhanxiang Zhou
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.